Kanan Pujara
Impact in
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer Genomics and Diagnostics 2
-
- DNA Repair Mechanisms 4
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 3
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Jeremy Stinson (3 shared papers)Thomas M. Holcomb (2 shared papers)Robert L. Yauch (2 shared papers)Somasekar Seshagiri (3 shared papers)J. Fernando Bazán (1 shared paper)Zhengyan Kan (2 shared papers)Jennifer A. Low (1 shared paper)Christina Petersen Ahn (1 shared paper)
- Journals
- Cancer Cell (3 papers)Human Mutation (3 papers)Cancer Research (2 papers)Nature (2 papers)Science (1 paper)
- Partner nations
- United StatesGermanyBrazil
In The Last Decade
Kanan Pujara
18 papers receiving 5.5k citations
Kanan Pujara's Hit Papers
Peers
Comparison fields: 5 of 118
- Genetics 1.6k
- Cancer Research 1.4k
- Molecular Biology 3.4k
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 763
Countries citing papers authored by Kanan Pujara
This map shows the geographic impact of Kanan Pujara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanan Pujara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanan Pujara more than expected).
Fields of papers citing papers by Kanan Pujara
This network shows the impact of papers produced by Kanan Pujara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanan Pujara. The network helps show where Kanan Pujara may publish in the future.
Co-authors
The 25 scholars most cited alongside Kanan Pujara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma Hit paper breakdown → | 2010 | 1943 |
| 2 | Diverse somatic mutation patterns and pathway alterations in human cancers Hit paper breakdown → | 2010 | 882 |
| 3 | Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma Hit paper breakdown → | 2009 | 732 |
| 4 | Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 Hit paper breakdown → | 2011 | 662 |
| 5 | 2006 | 417 | |
| 6 | 2011 | 375 | |
| 7 | 2013 | 306 | |
| 8 | 2007 | 109 | |
| 9 | 2005 | 75 | |
| 10 | 2011 | 47 | |
| 11 | 2003 | 32 | |
| 12 | 2000 | 16 | |
| 13 | 2003 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 2015 | 14 | |
| 16 | 2014 | 11 | |
| 17 | 2007 | 6 | |
| 18 | 2015 | 1 |
About Kanan Pujara
Kanan Pujara is a scholar working on Cancer Research, Molecular Biology, Genetics, Genetics and Oncology, having authored 18 papers that have together received 5.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (4 papers), Ubiquitin and proteasome pathways (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Genomics and Diagnostics (2 papers), Glioma Diagnosis and Treatment (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Genomics and Rare Diseases (2 papers). The work is most often cited by research in Genetics (1.6k citations), Cancer Research (1.4k citations), Molecular Biology (3.4k citations), Oncology (1.2k citations) and Pulmonary and Respiratory Medicine (763 citations). Kanan Pujara has collaborated with scholars based in United States, Germany and Brazil. Frequent co-authors include Jeremy Stinson, Thomas M. Holcomb, Robert L. Yauch, Somasekar Seshagiri, J. Fernando Bazán, Zhengyan Kan, Jennifer A. Low, Christina Petersen Ahn, Charles M. Rudin and Bruno Alicke. Their work appears in journals such as Cancer Cell, Human Mutation, Cancer Research, Nature and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.